Truist Securities Maintains Hold on Teladoc Health, Lowers Price Target to $17
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Jailendra Singh has maintained a Hold rating on Teladoc Health (TDOC) and reduced the price target from $23 to $17.
March 06, 2024 | 5:25 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Truist Securities has maintained a Hold rating on Teladoc Health and lowered the price target from $23 to $17.
The reduction in price target by Truist Securities from $23 to $17 indicates a negative outlook on Teladoc Health's stock price in the short term. This adjustment reflects analyst Jailendra Singh's assessment of the company's future performance, potentially influencing investor sentiment and leading to a decrease in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100